WHO ICTRP trial
regulatory T cells in treatment of patients with acute GVHD after allogeneic…
IRCT20230801058996N8 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20230801058996N8 |
|---|---|
| Public title | regulatory T cells in treatment of patients with acute GVHD after allogeneic stem cell transplantation |
| Scientific title | Evaluation of efficacy and safety of regulatory T cells in treatment of patients with acute GVHD after allogeneic stem cell transplantation, Clinical Trial phase I-II |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Graft Versus Host Disease. Graft-versus-host disease;D89.81 |
| Interventions | Intervention group: Intervention group: Treg preparation and injection is performed after Haploidentical HSCT. Treg suspended in 50 ml of 5% albumin solution is injected intravenously (central vein) over 20-30 minutes. In Treg injection… |
| Registration date | Jan 27, 2026 |
| Target size | 20 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: